Kathy L. Hibbs Sells 38,548 Shares of 23andMe Holding Co. (NASDAQ:ME) Stock

23andMe Holding Co. (NASDAQ:ME) insider Kathy L. Hibbs sold 38,548 shares of the business’s stock in a transaction dated Thursday, April 18th. The shares were sold at an average price of $0.47, for a total transaction of $18,117.56. Following the completion of the transaction, the insider now owns 1,252,315 shares in the company, valued at approximately $588,588.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

23andMe Stock Performance

ME stock opened at $0.48 on Friday. The firm’s 50-day moving average price is $0.54 and its two-hundred day moving average price is $0.72. 23andMe Holding Co. has a 12-month low of $0.35 and a 12-month high of $2.21.

23andMe (NASDAQ:ME) last announced its quarterly earnings results on Wednesday, February 7th. The company reported ($0.17) earnings per share (EPS) for the quarter. 23andMe had a negative net margin of 210.48% and a negative return on equity of 52.99%. The company had revenue of $44.75 million for the quarter, compared to analysts’ expectations of $56.30 million.

Hedge Funds Weigh In On 23andMe

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. boosted its stake in 23andMe by 3.1% during the third quarter. Vanguard Group Inc. now owns 28,145,216 shares of the company’s stock worth $27,518,000 after acquiring an additional 834,504 shares in the last quarter. BlackRock Inc. boosted its stake in 23andMe by 4.9% during the second quarter. BlackRock Inc. now owns 19,330,109 shares of the company’s stock worth $33,828,000 after acquiring an additional 910,127 shares in the last quarter. State Street Corp boosted its stake in 23andMe by 10.3% during the second quarter. State Street Corp now owns 6,183,243 shares of the company’s stock worth $10,821,000 after acquiring an additional 576,924 shares in the last quarter. Geode Capital Management LLC boosted its stake in 23andMe by 4.7% during the second quarter. Geode Capital Management LLC now owns 5,617,120 shares of the company’s stock worth $9,830,000 after acquiring an additional 254,321 shares in the last quarter. Finally, Voya Investment Management LLC boosted its stake in 23andMe by 127.0% during the fourth quarter. Voya Investment Management LLC now owns 5,517,344 shares of the company’s stock worth $5,040,000 after acquiring an additional 3,086,866 shares in the last quarter. Hedge funds and other institutional investors own 36.10% of the company’s stock.

Analysts Set New Price Targets

Separately, Citigroup decreased their price objective on shares of 23andMe from $0.85 to $0.47 and set a “neutral” rating on the stock in a research report on Tuesday, April 16th.

23andMe Company Profile

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.